Thomas Cummins
About Thomas Cummins
Thomas Cummins is a Principal Scientist at Bristol Myers Squibb in San Diego, California, with extensive experience in the biotechnology industry and a strong background in medicinal chemistry.
Current Role at Bristol Myers Squibb
Thomas Cummins is currently a Principal Scientist at Bristol Myers Squibb in San Diego, California. He started his tenure at the company in November 2020. Bristol Myers Squibb is a global biopharmaceutical company, and his role involves significant responsibilities in medicinal chemistry and the discovery of new pharmaceutical agents.
Previous Experience at Amgen
Before joining Bristol Myers Squibb, Thomas Cummins worked as a Senior Scientist at Amgen in Thousand Oaks, California. From 2019 to 2020, for a span of one year, he engaged in various scientific research projects that likely focused on advancing Amgen's biopharmaceutical initiatives.
Tenure at Nurix Therapeutics
Thomas Cummins worked at Nurix Therapeutics in the San Francisco Bay Area for five years. He started as a Scientist from 2014 to 2017 and then was promoted to Scientist II, a role he held from 2017 to 2019. His work there involved applying modern medicinal chemistry approaches in drug discovery and development programs.
Research Career at University of Utah
Cummins spent six years as a Research Assistant at the University of Utah in Salt Lake City. From 2008 to 2014, he was involved in various research projects, contributing significantly to his field. This period also coincides with his time as a Ph.D. candidate in Chemistry at the same institution.
Educational Background in Chemistry
Thomas Cummins earned his Ph.D. in Chemistry from the University of Utah, where he studied from 2008 to 2014. Prior to that, he obtained his Bachelor of Science (B.S.) degree in Chemistry from San Diego State University between 2007 and 2009. His educational background provided a strong foundation for his career in the biotechnology industry.